Intuitive Surgical, Inc. Stock

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 16:00:00 2024-07-22 EDT 5-day change 1st Jan Change
461.1 USD +1.34% Intraday chart for Intuitive Surgical, Inc. +5.46% +36.68%
Sales 2024 * 8.09B 11.13B Sales 2025 * 9.38B 12.91B Capitalization 164B 226B
Net income 2024 * 2.02B 2.77B Net income 2025 * 2.33B 3.21B EV / Sales 2024 * 19.6 x
Net cash position 2024 * 5.07B 6.98B Net cash position 2025 * 7.5B 10.32B EV / Sales 2025 * 16.7 x
P/E ratio 2024 *
82 x
P/E ratio 2025 *
71 x
Employees 13,676
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.27%
More Fundamentals * Estimated data
Dynamic Chart
1 day+1.34%
1 week+5.46%
Current month+3.66%
1 month+6.60%
3 months+24.99%
6 months+22.70%
Current year+36.68%
More quotes
1 week
413.82
Extreme 413.82
468.78
1 month
413.82
Extreme 413.82
468.78
Current year
320.26
Extreme 320.26
468.78
1 year
254.85
Extreme 254.85
468.78
3 years
180.07
Extreme 180.07
468.78
5 years
120.17
Extreme 120.1667
468.78
10 years
48.72
Extreme 48.7222
468.78
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 96-03-31
President 56 96-02-29
Director of Finance/CFO 52 13-03-31
Members of the board TitleAgeSince
Director/Board Member 65 17-03-31
Director/Board Member 66 07-10-18
Director/Board Member 71 10-03-31
More insiders
Date Price Change Volume
24-07-22 461.1 +1.34% 2,574,379
24-07-19 455 +9.34% 4,201,310
24-07-18 416.1 -2.37% 3,856,042
24-07-17 426.2 -2.69% 2,388,617
24-07-16 438 +0.17% 1,436,106

Delayed Quote Nasdaq, July 22, 2024 at 04:00 pm

More quotes
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
461.1 USD
Average target price
466.3 USD
Spread / Average Target
+1.13%
Consensus